1. Home
  2. AGEN vs ATLX Comparison

AGEN vs ATLX Comparison

Compare AGEN & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.23

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$3.54

Market Cap

124.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
ATLX
Founded
1994
2011
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
124.5M
IPO Year
1999
2012

Fundamental Metrics

Financial Performance
Metric
AGEN
ATLX
Price
$3.23
$3.54
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$14.50
$12.00
AVG Volume (30 Days)
672.7K
855.9K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
47.08
EPS
1.02
N/A
Revenue
$42,877,086.00
$92,491.00
Revenue This Year
$107.63
$64,564.67
Revenue Next Year
N/A
$785.59
P/E Ratio
$3.33
N/A
Revenue Growth
89.95
N/A
52 Week Low
$2.71
$3.60
52 Week High
$7.34
$8.25

Technical Indicators

Market Signals
Indicator
AGEN
ATLX
Relative Strength Index (RSI) 42.85 32.36
Support Level $2.93 N/A
Resistance Level $3.26 $5.23
Average True Range (ATR) 0.22 0.25
MACD 0.01 -0.07
Stochastic Oscillator 36.93 0.71

Price Performance

Historical Comparison
AGEN
ATLX

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.

Share on Social Networks: